| 1. | Induction and mechanisms of cross - resistance to quinolones in ureaplasma urealyticum
体外诱导解脲脲原体对喹诺酮类药物交叉耐药的研究 |
| 2. | Clinical analysis on adverse reaction of central nervous system induced by fluoroquinolone
氟喹诺酮类药物致中枢神经系统不良反应的临床分析 |
| 3. | Comparison of hepatic toxic injury induced by concomitant use of fluoroguinolones and antituberculotics in mice
氟喹诺酮类联用抗结核药肝毒性比较 |
| 4. | Rapid detection of the mutations of resistance - fluoroquinolone neisseria gonorrhoeae gene by a dna microarray
快速检测淋球菌耐喹诺酮类药物基因突变 |
| 5. | Analysis of the residuals of trace quinolones in the pig viscera by mekc using sweeping technique
猪脏器中痕量喹诺酮类药物的胶束毛细管电泳在线富集技术检测 |
| 6. | Studies on interaction of new medicine of quinolone - class with hsa and bsa by using fluorescence enhancement and fluorescence quenching theory
用荧光猝灭和荧光加强两种理论研究喹诺酮类新药与白蛋白的作用 |
| 7. | It was shown that there was a relationship between the degree of quinolone - resistance to clinical poultry salmonella and the amino acid mutations in qrdr of the gyra gene
由此表明禽源沙门氏菌gyra基因qrdr区的变异与菌株对喹诺酮类药物的耐药性有一定相关性。 |
| 8. | Fluoroquinolones enterprises in china need to revise product lines reasonably based on product strategy and analyzing the competition trends so as to win more superiority in competition
氟喹诺酮类原料药企业需要结合自身产品战略，分析竞争形势，合理调整产品线，以获得更强竞争优势。 |
| 9. | Progresses on the synthesis and classification of the metal complexes based on quinolone antibacterial drugs , their structures , properties as well as their reaching trend in future are reviewed
摘要本文综述了喹诺酮类抗菌药物金属配合物的合成、分类、结构、性质等方面的研究现状，展望了此类研究的发展趋势。 |
| 10. | The sales value in 2004 is rmb 1 , 500 , 000 , 000 , in which usd 80 , 000 , 00 is for export . it is the main production base of fat - soluble vitamins and quinolones in china , and national key high - tech enterprise
我司2004年销售收入15亿元（其中出口8000万美元） ，是我国脂溶性维生素类，喹诺酮类药物的重要生产基地，国家级重点高新技术企业。 |
